Active Pharmaceutical Ingredient Market: Growth, Size, Share, and Trends

This research study involved the extensive use of Secondary sources, directories, and databases were used extensively to identify and collect helpful information for this technical, market-oriented, and financial study of the global active pharmaceutical ingredients market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess the market growth prospects. The global size of the active pharmaceutical ingredients market (estimated through various secondary research approaches) was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include directories; databases such as Bloomberg Businessweek, Factiva, and white papers; and clinicaltrial.gov, among others. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global active pharmaceutical ingredients market, which was validated through primary research. Some of the key secondary sources referred to for this study include, Active Pharmaceutical Ingredients Committee (APIC), Chemical Pharmaceutical Generic Association (CPA), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), European Federation of Pharmaceutical Industries and Associations (EFPIA), International Pharmaceutical Congress Advisory Association (IPCAA), European Generic and Biosimilar Medicines Association (EGBMA), World Health Organization (WHO), Centers for Disease Control and Prevention (CDC).

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global active pharmaceutical ingredients market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand-side personnel (such as contract research organizations (specialists), academic medical researchers, scientists, and pharmaceutical and biopharmaceutical company experts) and supply-side (such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various companies and organizations operating in the market) across four major regions—North America, Europe, the Asia Pacific, and Rest of the World. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants respectively. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the active pharmaceutical ingredients market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

• The key players in the industry and market have been identified through extensive primary and secondary research.
• The revenues generated from the active pharmaceutical ingredients business of leading players have been determined through primary and secondary research.
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global Active Pharmaceutical Ingredients Market: Bottom Up Approach

To know about the assumptions considered for the study, Request for Free Sample Report

Global Active Pharmaceutical Ingredients Market: Top Down Approach

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

Active Pharmaceutical Ingredients (API), also known as bulk pharmaceuticals or drug substances, are the primary biologically active components in medications that produce the intended therapeutic effect. These substances are responsible for the pharmacological activity of the drug product.

Key Stakeholders

• Manufacturers of APIs
• Distributors and Suppliers of APIs
• Potential Investors in the APIs Market
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Manufacturing Organizations
• Life Science Research Centers
• Healthcare Payers
• Academic and Government Research Institutes
• Venture Capitalists and Investors
• Government Organizations
• Private Research Firms
• Contract Research Organizations (CROs)

Report Objectives

• To define, describe, and forecast the global Active pharmaceutical ingredients Market based on type, synthesis, type of drug, potency, therapeutic applications, end user, and region
• To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
• To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific,  Latin America, Middle East and Africa.
• To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
• To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographical Analysis

• Further breakdown of the Europe Active pharmaceutical ingredients Market, by country
• Further breakdown of the Asia Pacific Active pharmaceutical ingredients Market, by country
• Further breakdown of the Latin America Active pharmaceutical ingredients Market, by country
• Further breakdown of the Middle East Active pharmaceutical ingredients Market, by country

Company Information

• Detailed analysis and profiling of additional market players (up to five)

Segment Analysis

• Further breakdown of the product segment as per the product portfolio of prominent players operating in the market.